Scholar Rock Holding Corporation (SRRK)

Scholar Rock Holding Corporation (SRRK $39.98)
- $39.98 Cap: $3.68B
- View SRRK Profile
- View Questions on SRRK

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Crinetics Pharmaceuticals Inc. (CRNX $30.47)
- $30.47 Cap: $2.98B
- View CRNX Profile
- View Questions on CRNX
Scholar Rock Holding Corporation (SRRK $39.98)
- $39.98 Cap: $3.68B
- View SRRK Profile
- View Questions on SRRK
ImmunityBio Inc. (IBRX $2.71)
- $2.71 Cap: $2.42B
- View IBRX Profile
- View Questions on IBRX

Q: Hello 5i Team,

Your thoughts on these 3 names. SRRK & CRNX gave us good returns with the recent run and I intend to replace with IBRX.

Thank you!

Read Answer Asked by Nhung on October 31, 2024